Adrenal atrophy history and symptoms: Difference between revisions
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
The most common signs and symptoms of adrenal atrophy are fatigue, weight loss, salt craving, abdominal pain and myalgia. | The most common signs and symptoms of adrenal atrophy are [[fatigue]], weight loss, [[salt craving]], [[abdominal pain]] and [[myalgia]]. | ||
==History and Symptoms== | ==History and Symptoms== | ||
Line 13: | Line 13: | ||
*[[Weakness]] | *[[Weakness]] | ||
*Gastrointestinal problems | *Gastrointestinal problems | ||
*Diffuse myalgia or arthralgia | *Diffuse [[myalgia]] or [[arthralgia]] | ||
*[[Lightheadedness]] | *[[Lightheadedness]] | ||
*Salt cravings | *[[Salt cravings]] | ||
*[[Depression]] | *[[Depression]] | ||
*[[Irritability]] | *[[Irritability]] | ||
*[[Insomnia]] | *[[Insomnia]] | ||
*[[Headache]]s | *[[Headache]]s | ||
*Psychosis or mania in some cases<ref name="pmid10084558">{{cite journal |vauthors=Abdu TA, Elhadd TA, Neary R, Clayton RN |title=Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease |journal=J Clin Endocrinol Metab |volume=84 |issue=3 |pages=838–43 |date=March 1999 |pmid=10084558 |doi=10.1210/jcem.84.3.5535 |url=}}</ref><ref name="pmid19382991">{{cite journal |vauthors=Husebye ES, Perheentupa J, Rautemaa R, Kämpe O |title=Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I |journal=J Intern Med |volume=265 |issue=5 |pages=514–29 |date=May 2009 |pmid=19382991 |doi=10.1111/j.1365-2796.2009.02090.x |url=}}</ref> | *[[Psychosis]] or [[mania]] in some cases<ref name="pmid10084558">{{cite journal |vauthors=Abdu TA, Elhadd TA, Neary R, Clayton RN |title=Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease |journal=J Clin Endocrinol Metab |volume=84 |issue=3 |pages=838–43 |date=March 1999 |pmid=10084558 |doi=10.1210/jcem.84.3.5535 |url=}}</ref><ref name="pmid19382991">{{cite journal |vauthors=Husebye ES, Perheentupa J, Rautemaa R, Kämpe O |title=Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I |journal=J Intern Med |volume=265 |issue=5 |pages=514–29 |date=May 2009 |pmid=19382991 |doi=10.1111/j.1365-2796.2009.02090.x |url=}}</ref> | ||
==References== | ==References== |
Revision as of 04:36, 5 February 2022
Adrenal atrophy Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Adrenal atrophy history and symptoms On the Web |
American Roentgen Ray Society Images of Adrenal atrophy history and symptoms |
Risk calculators and risk factors for Adrenal atrophy history and symptoms |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maryam Hadipour, M.D.[2]
Overview
The most common signs and symptoms of adrenal atrophy are fatigue, weight loss, salt craving, abdominal pain and myalgia.
History and Symptoms
The symptoms and signs of adrenal insufficiency depend upon the rate and extent of loss of adrenal function, whether mineralocorticoid production is preserved, and the degree of stress. The onset of adrenal insufficiency is often very gradual, and it may go undetected until an illness or other stress precipitates adrenal crisis. However, the most common symptoms in patients with adrenal atrophy are as follows:
- Fatigue
- Weight loss
- Weakness
- Gastrointestinal problems
- Diffuse myalgia or arthralgia
- Lightheadedness
- Salt cravings
- Depression
- Irritability
- Insomnia
- Headaches
- Psychosis or mania in some cases[1][2]
References
- ↑ Abdu TA, Elhadd TA, Neary R, Clayton RN (March 1999). "Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease". J Clin Endocrinol Metab. 84 (3): 838–43. doi:10.1210/jcem.84.3.5535. PMID 10084558.
- ↑ Husebye ES, Perheentupa J, Rautemaa R, Kämpe O (May 2009). "Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I". J Intern Med. 265 (5): 514–29. doi:10.1111/j.1365-2796.2009.02090.x. PMID 19382991.